Clinical Trial Update: Immune Checkpoint Inhibitor and MR-guided SBRT for Limited Progressive Metastatic Carcinoma. [NA]

View source ↗

Summary

Terminated clinical trial evaluating the combination of an immune checkpoint inhibitor with MR-guided SBRT for limited progressive metastatic carcinoma, with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma

Drugs mentioned

• Immune checkpoint inhibitor

Snippet

Sponsor: Baptist Health South Florida | Conditions: Metastatic Carcinoma | NA | Status: TERMINATED | Results posted: 2025-01-03